Liver Diseases  >>  glycosylated recombinant human interleukin-7 (CYT107)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glycosylated recombinant human interleukin-7 (CYT107) / Revimmune
ECLIPSE 1, NCT01025596: Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy

Completed
1/2
10
Europe
Interleukin-7
Cytheris SA
Hepatitis C
02/11
03/12

Download Options